Catabasis Pharmaceuticals Inc (CATB)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -69.059 | -94.186 | -90.667 | -64.962 | -83.599 | -222.795 | -28.946 | -30.04 |
| Return on Equity (%) | -90.627 | -133.881 | -110.712 | -74.419 | -97.658 | -239.185 | -30.178 | -31.396 |
| Return on Invested Capital (%) | -81.227 | -125.636 | -113.612 | -77.404 | -98.837 | -239.572 | -31.335 | -36.181 |
| Operating Margin (%) | N/A | -5380.4 | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | -5472.8 | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | 1.546 | 0.499 | 3.039 | 2.873 | 2.025 | 9.396 | 8.044 | 6.698 |
| Earnings Per Share | -1.916 | -1.157 | -2.25 | -2.115 | -1.857 | -14.974 | -1.885 | -2.008 |
| Cash Per Share | 1.254 | 0.692 | 1.33 | 0.796 | 1.241 | 6.646 | 0.746 | 4.836 |
| Working Capital Per Share | 1.658 | 0.484 | 3.022 | 2.728 | 1.988 | 9.363 | 7.95 | 6.596 |
| Operating Profit Per Share | N/A | 0.021 | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | -1.916 | -1.157 | -2.25 | -2.115 | -1.857 | -14.974 | -1.885 | -2.008 |
| EBITDA Per Share | -1.916 | -1.157 | -2.25 | -2.115 | -1.857 | -14.974 | -1.885 | -2.008 |
| Free Cash Flow Per Share | -1.913 | -1.168 | -2.261 | -2.116 | -1.856 | -13.095 | -1.881 | -2.008 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.748 | 2.903 | 9.33 | 7.742 | 7.25 | 24.423 | 25.131 | 21.727 |
| Quick Ratio | 4.628 | 2.721 | 9.007 | 7.203 | 7.031 | 24.122 | 24.993 | 21.359 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 18.82M | 23.65M | 11.5M | 12.43M | 20.08M | 13.02M | 27.5M | N/A |
| Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | N/A | 15.75M | 27.5M | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | 32.286 | N/A | N/A | N/A | 33.826 |
| Quick Ratio | N/A | N/A | N/A | 31.969 | N/A | N/A | N/A | 33.424 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 309.97M |
| Price to Earnings Ratio | -4.25 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.77 |
| Price to Book Ratio | 1.27 |
| Dividend Yield | - |
| Shares Outstanding | 36.3M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
